Engineers Gate Manager’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
FCM
AC
VCM
LCM
VPM
EAM
Engineers Gate Manager's AGIO Position: Q1 2026 in Review
Engineers Gate Manager reduced its Agios Pharmaceuticals (AGIO) stake by 41% in Q1 2026, selling an estimated $573K and leaving 28,920 shares worth $978K. The position accounts for 0.01% of the portfolio, ranked #1066.
Engineers Gate Manager first reported a position in AGIO in Q1 2019 and has held it in 17 quarters since. The position peaked at $1.98M in Q4 2024. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.
- Engineers Gate Manager held 28,920 shares of Agios Pharmaceuticals worth $978K as of Q1 2026.
- Engineers Gate Manager sold 20,208 Agios Pharmaceuticals shares in Q1 2026, an estimated $573K.
- Agios Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1066 holding.
- Engineers Gate Manager first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 17 quarters since.
- Engineers Gate Manager's Agios Pharmaceuticals position peaked at $1.98M in Q4 2024.
- 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.
Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.